Mylab Discovery Solutions has completed expansion of its production capacity to manufacture COVID-19 RT-PCR tests. As per the production plan, Mylab will scale-up manufacturing to 2 lakh tests per day from the second week of May.
Adar Poonawalla, CEO, Serum Institute of India said, "It overwhelms me to see our efforts with Mylab in making India self-reliant in combating COVID-19 fructified.
As our production capacity increases from 20,000 tests per day to 2 lakh COVID-19 tests per day, we will now be able to meet India's growing demand for testing completely." "This is an important milestone for the Make in India initiative as it sets a precedent of health institutions coming together to work towards the interest of public health.